Otiprio® (ciprofloxacin otic suspension) – New Indication
March 2, 2018 - Otonomy announced the FDA approval of Otiprio® (ciprofloxacin otic suspension) 6% for the treatment of acute otitis externa (AOE) in patients 6 months of age and older due to Pseudomonas aeruginosa and Staphylococcus aureus.
Download PDF
